Leptin and adiponectin: Pathophysiological role and possible therapeutic target of inflammation in ischemic stroke

Reviews in the Neurosciences

Volumn 28, Issue 3, 2017, Pages 295-306

  Gairolla, Jitender ^a   Kler, Rupinder ^a   Modi, Manish ^a   Khurana, Dheeraj ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

adiponectin; adipose tissue; atherosclerosis; ischemic stroke; leptin

Indexed keywords

ADIPONECTIN; LEPTIN;

ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; DIABETES MELLITUS; HUMAN; HYPERTENSION; INFLAMMATION; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; THROMBOSIS; ANIMAL; CEREBROVASCULAR ACCIDENT; ISCHEMIA; METABOLISM;

ADIPONECTIN; ANIMALS; HUMANS; INFLAMMATION; ISCHEMIA; LEPTIN; OBESITY; STROKE;

EID: 85016828624     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/revneuro-2016-0055     Document Type: Article

References (124)

1. Adya, R., Tan, B. K., Randeva H. S. (2015). Differential effects of leptin, adiponectin in endothelial angiogenesis. J Diabetes Res. 2015, 648239.
2. Ahima, R. S., Osei, S. Y. (2004). Leptin signaling. Physiol. Behav. 81, 223-241.
3. Aleidi, S., Issa, A., Bustanji, H., Khalil M., Bustanji Y. (2015). Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients. Saudi Pharm. J. 23, 250-256.
4. Aprahamian, T. R., Sam, F. (2011). Adiponectin in cardiovascular inflammation, obesity. Int. J. Inflam. 2011, 376909.
5. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999). Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83.
6. Bailleul, B., Akerblom, I., Strosberg, A. D. (1997). The leptin receptor promoter controls expression of a second distinct protein. Nucleic Acids Res. 25, 2752-2758.
7. Bang, O. Y., Saver, J. L., Ovbiagele, B., Choi, Y. J., Yoon, S. R., Lee, K. H. (2007). Adiponectin levels in patients with intracranial atherosclerosis. Neurology 22, 1931-1937.
8. Beltowski, J. (2006). Leptin, atherosclerosis. Atherosclerosis 189, 47-60.
9. Berg, A. H., Combs, T. P., Du, X., Brownlee, M., Scherer, P. E. (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med. 7, 947-953.
10. Berg, A. H., Combs, T. P., Scherer, P. E. (2002). ACRP30/adiponectin: An adipokine regulating glucose, lipid metabolism. Trends Endocrinol. Metab. 13, 84-89.
11. Bidulescu, A., Liu, J., Chen, Z., Hickson, D. A., Musani, S. K., Samdarshi, T. E., Fox, E. R., Taylor, H. A., Gibbons, G. H. (2013). Associations of adiponectin, leptin with incident coronary heart disease, ischemic stroke in African Americans: The Jackson Heart Study. Front. Public Health 1, 16.
12. Blumer, R. M., van Roomen, C. P., Meijer, A. J., Houben-Weerts, J. H., Sauerwein, H. P., Dubbelhuis, P. F. (2008). Regulation of adiponectin secretion by insulin, amino acids in 3T3-L1 adipocytes. Metabolism 57, 1655-1662.
13. Bodary, P. F., Eitzman, D. T. (2006). Adiponectin: Vascular protection from the fat Arterioscler. Thromb. Vasc. Biol. 26, 235-236.
14. Bodles, A. M., Banga, A., Rasouli, N., Ono, F., Kern, P. A., Owens, R. J. (2006). Pioglitazone increases secretion of high-molecularweight adiponectin from adipocytes. Am. J. Physiol. Endocrinol. Metab. 291, E1100-E1105.
15. Bouloumie, A., Marumo, T., Lafontan, M., Busse, R. (1999). Leptin induces oxidative stress in human endothelial cells. FASEB J. 13, 1231-1238.
16. Bouloumié, A., Curat, C. A., Sengenes, C., Lolmede, K., Alexandra M., Busse, R. (2005). Role of Macrophage tissue infiltration in metabolic diseases. Curr. Opin. Clin. Nutr. Metab. Care 8, 347-54.
17. Buechler, C., Wanninger, J., Neumeier, M. (2010). Adiponectin receptor binding proteins-recent advances in elucidating adiponectin signalling pathways. FEBS Lett. 584, 4280-4286.
18. Caselli, C., D'Amico, A., Cabiati, M., Prescimone, T., Del Ry, S., Giannessi, D. (2014). Back to the heart: The protective role of adiponectin. Pharmacol. Res. 82, 9-20.
19. Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., Quon, M. J. (2003). Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 278, 45021-45026.
20. Chen, M. P., Tsai, J. C., Chung, F. M., Yang, S. S., Hsing, L. L., Shin, S. J., Lee, Y. J. (2005). Hypoadiponectinemia is associated with ischemic cerebrovascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 821-826.
21. Chen, K., Li, F., Li, J., Cai, H., Strom, S., Bisello, A., Kelley, D. E., Friedman-Einat, M., Skibinski, G. A., McCrory, M. A. (2006). Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med. 12, 425-432.
22. Chen, B., Liao, W. Q., Xu, N., Xu., H., Wen, J. Y., Yu, C. A., Liu, X. Y., Li, C. L., Zhao, S. M., Campbell, W. (2009). Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 1273, 129-137.
23. Cioffi, J. A., Shafer, A. W., Zupancic, T. J., Smith-Gbur, J., Mikhail, A., Platika, D., Snodgrass, H. R. (1996). Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis, reproduction. Nat. Med. 2, 585-589.
24. Clement, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J. M., et al. (1998). A mutation in the human leptin receptor gene causes obesity, pituitary dysfunction. Nature. 392. 398-401.
25. Corsonello, A., Perticone, F., Malara, A., De Domenico, D., Loddo, S., Buemi, M., Ientile, R., Corica, F. (2003). Leptin-dependent platelet aggregation in healthy, overweight, obese subjects. Int. J. Obes. Relat. Metab. Disord. 27, 566-573.
26. Deb, P., Sharma, S., Hassan, K. M. (2010). Pathophysiologic mechanisms of acute ischemic stroke: An overview with emphasis on therapeutic significance beyond thrombolysis. Pathophysiology 17, 197-218.
27. Dichgans, M. (2007). Genetics of ischaemic stroke. Lancet Neurol. 6, 149-161.
28. Fazeli, M., Zarkesh-Esfahani, H., Wu, Z., Maamra, M., Bidlingmaier, M., Pockley, A. G., Watson, P., Matarese, G., Strasburger, C. J., Ross, R. J. (2006). Identification of a monoclonal antibody against the leptin receptor that acts as an antagonist, blocks human monocyte, T cell activation. J. Immunol. Methods 312, 190-200.
29. Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014). Global, regional burden of stroke during 1990-2010: Findings from the Global Burden of Disease Study. Lancet 383, 245-254.
30. Fisman, E. Z., Tenenbaum, A. (2014). Adiponectin: A manifold therapeutic target for metabolic syndrome, diabetes, coronary disease Cardiovasc. Diabetol. 13, 103.
31. Friedman, J. M. (2009). Leptin at 14 y of age: An ongoing story. Am. J. Clin. Nutr. 89, 973S-979S.
32. Fruhbeck, G. (2006). Intracellular signalling pathways activated by leptin. Biochem. J. 393, 7-20.
33. Grunfeld, C., Zhao, C., Fuller, J., Pollack, A., Moser, A., Friedman, J., and. Feingold, K. R. (1996). Endotoxin, cytokines induce expression of leptin, the ob gene product, in hamsters. J. Clin. Invest. 97, 2152-2157.
34. Gu, P., Xu, A. (2013). Interplay between adipose tissue, blood vessels in obesity, vascular dysfunction. Rev. Endocr. Metab. Disord. 14, 49-58.
35. Hada, Y., Yamauchi, T., Waki, H., Tsuchida, A., Hara, K., Yago, H., Miyazaki, O., Ebinuma, H., Kadowaki, T. (2007). Selective purification, characterization of adiponectin multimer species from human plasma. Biochem. Biophys. Res. Commun. 356, 487-493.
36. Hattori, Y., Nakano, Y., Hattori, S., Tomizawa, A., Inukai, K., Kasai, K. (2008). High molecular weight adiponectin activates AMPK, suppresses cytokine-induced NF-kappaB activation in vascular endothelial cells. FEBS Lett. 582, 1719-1724.
37. Hribal, M. L., Fiorentino, T. V., Sesti, G. (2014). Role of C reactive protein (CRP) in leptin resistance. Curr. Pharm. Des. 20, 609-615.
38. Hu, E., Liang, P., Spiegelman, B. M. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703.
39. Hukshorn, C. J., Saris, W. H. (2004). Leptin, energy expenditure. Curr. Opin. Clin. Nutr. Metab. Care 7, 629-633.
40. Imagawa, K., Numata, Y., Katsuura, G., Sakaguchi, I., Morita, A., Kikuoka, S., Matumoto, Y., Tsuji, T., Tamaki, M., Sasakura, K., et al. (1998). Structure-function studies of human leptin. J. Biol. Chem. 273, 35245-35249.
41. Isse, N., Ogawa, Y., Tamura, N., Masuzaki, H., Mori, K., Okazaki, T., Satoh, N., Shigemoto, M., Yoshimasa, Y., Nishi S., et al. (1995). Structural organization, chromosomal assignment of the human obese gene. J. Biol. Chem. 270, 27728-27733.
42. Iwashima, Y., Katsuya, T., Ishikawa, K., Ouchi, N., Ohishi, M., Sugimoto, K., Fu, Y., Motone, M., Yamamoto, K., Matsuo, A., et al. (2004). Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43, 1318-1323.
43. Jaleel, A., Aqil, S., Jaleel, S., Jaleel, F. (2010). Adipocytokines in subjects with, without ischemic cerebrovascular disease. Acta Neurol. Belg. 110, 234-238.
44. Jin, R., Yang, G., Li, G. (2010). Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J. Leukoc. Biol. 87, 779-789.
45. Juge-Aubry, C. E., Henrichot, E., Meier, C. A. (2005). Adipose tissue: A regulator of inflammation. Best Pract. Res. Clin. Endocrinol. Metab. 19, 547-66.
46. Kadowaki, T., Yamauchi, T. (2005). Adiponectin, adiponectin receptors. Endocr. Rev. 26, 439-451.
47. Kantorova, E., Chomova, M., Kurca, E., Sivak, S., Zelenak, K., Kucera, P., Galajda, P. (2011). Leptin, adiponectin, ghrelin, new potential mediators of ischemic stroke. Neurol. Endocrinol. Lett. 32, 716-721.
48. Kantorová, E., Jesenská, ., ierny, D., Zeleák, K., Sivák, S., Staník, M., Galajda, P., Nosá, V., Kura, E. (2015). The intricate network of adipokines, stroke. Int. J. Endocrinol. 2015, 967698.
49. Kato, H., Kashiwagi, H., Shiraga, M., Tadokoro, S., Kamae, T., Ujiie, H., Honda, S., Miyata, S., Ijiri, Y., Yamamoto, J., et al. (2006). Adiponectin acts as an endogenous antithrombotic factor. Arterioscler. Thromb. Vasc. Biol. 26, 224-230.
50. Kershaw, E. E., Flier, J. S. (2004). Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89, 2548-2556.
51. Kielar, D., Clark, J. S., Ciechanowicz, A., Kurzawski, G., Sulikowski, T., Naruszewicz, M. (1998). Leptin receptor isoforms expressed in human adipose tissue. Metabolism 47, 844-847.
52. Kim, B. J., Lee, S. H., Ryu, W. S., Kim, C. K., Yoon, B. W. (2012). Adipocytokines, ischemic stroke: Differential associations between stroke subtypes. J. Neurol. Sci. 312, 117-122.
53. Koh, K. K., Park., S. M., Quon, M. J. (2008). Leptin, cardiovascular disease: Response to therapeutic interventions. Circulation 117, 3238-3249.
54. Konstantinides, S., Schafer, K., Koschnick, S., Loskutoff, D. J. (2001). Leptin-dependent platelet aggregation, arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. J. Clin. Invest. 108, 1533-1540.
55. La Cava, A., Matarese, G. (2004). The weight of leptin in immunity. Nat. Rev. Immunol. 4, 371-379.
56. Lago, F., Dieguez, C., Gómez-Reino, J., Gualillo, O. (2007). Adipokines as emerging mediators of immune response, inflammation. Nat. Clin. Pract. Rheumatol. 3, 716-24.
57. Lakhan, S. E., Kirchgessner, A., Hofer, M. (2009). Inflammatory mechanisms in ischemic stroke: Therapeutic approaches. J. Transl. Med. 7, 97.
58. Lam, Q. L., Lu, L. (2007). Role of leptin in immunity. Cell. Mol. Immunol. 4, 1-13.
59. Lambertsen, K. L., Biber, K., Finsen, B. (2012). Inflammatory cytokines in experimental, human stroke. J. Cereb. Blood. Flow. Metab. 32, 1677-1698.
60. Lee, C. H., Hung, Y. J. (2015). Possible new therapeutic approach for obesity-related diseases: Role of adiponectin receptor agonists. J. Diabetes Invest. 6, 264-66.
61. Lee, G. H., Proenca, R., Montez, J. M., Carroll, K. M., Darvishzadeh, J. G., Lee, J. I., Friedman, J. M. (1996). Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635.
62. Libby, P. (2002). Inflammation in atherosclerosis. Nature 420, 868-74.
63. Liu, J., Wang, L. N. (2014). Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke, other vascular events in patients with stroke or transient ischaemic attack. Cochrane Database Syst. Rev. 1, CD010693.
64. Liu, J., Butler, K. R., Buxbaum, S. G., Sung, J. H., Campbell, B. W., Taylor, H. A. (2010). Leptinemia, its association with stroke, coronary heart disease in the Jackson Heart Study. Clin. Endocrinol. (Oxf). 72, 32-37.
65. Lord, G. M., Matarese, G., Howard, J. K., Baker, R. J., Bloom, S. R., Lechler, R. I. (1998). Leptin modulates the T-cell immune response, reverses starvation-induced immunosuppression. Nature 394, 897-901.
66. MacDougald, O. A., Burant, C. F. (2007). The rapidly expanding family of adipokines. Cell Metab. 6, 159-161.
67. Margetic, S., Gazzola, C., Pegg, G. G., Hill, R. A. (2002). Leptin: A review of its peripheral actions, interactions. Int. J. Obes. Relat. Metab. Disord. 26, 1407-1433.
68. Martin-Romero, C., Santos-Alvarez, J., Goberna, R., Sanchez-Margalet, V. (2000). Human leptin enhances activation, proliferation of human circulating T lymphocytes. Cell. Immunol. 199, 15-24.
69. Matarese, G. (2000). Leptin, the immune system: How nutritional status influences the immune response. Eur. Cytokine Netw. 11, 7-14.
70. Matarese, G., Moschos, S., Mantzoros, C. S. (2005). Leptin in Immunology. J. Immunol. 174, 3137-3142.
71. Matsubara, M., Maruoka, S., Katayose, S. (2002). Inverse relationship between plasma adiponectin, leptin concentrations in normal-weight, obese women. Eur. J. Endocrinol. 14, 173-180.
72. Matsumoto, M., Ishikawa, S., Kajii, E. (2008). Association of adiponectin with cerebrovascular disease: A nested case-control study. Stroke 39, 323-328.
73. Mertens, I., Ballaux, D., Funahashi, T., Matsuzawa, Y., Van der Planken, M., Verrijken, A., Ruige, J. B., Van Gaal, L. F. (2005). Inverse relationship between plasminogen activator inhibitor-I activity, adiponectin in overweight, obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol, inflammation. Thromb. Haemost. 94, 1190-1195.
74. Nakamura, Y., Ueshima, H., Okuda, N., Miura, K., Kita, Y., Okamura, T., Okayama, A., Choudhury, S. R., Rodriguez, B., Masaki, K. H., et al. (2013). Relation of serum leptin, adiponectin level to serum c-reactive protein: The INTERLIPID Study. Int. J. Vasc. Med. 2013, 601364.
75. Nakata, M., Yada, T., Soejima, N., Maruyama, I. (1999). Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 48, 426-429.
76. Nakatsuji, H., Kobayashi, H., Kishida, K., Nakagawa, T., Takahashi, S., Tanaka, H., Akamatsu, S., Funahashi, T., Shimomura, I. (2013). Binding of adiponectin, C1q in human serum, clinical significance of the measurement of C1q-adiponectin/total adiponectin ratio. Metabolism 62, 109-120.
77. Nishimura, M., Izumiya, Y., Higuchi, A., Shibata, R., Qiu, J., Kudo, C., Shin, H. K., Moskowitz, M. A., Ouchi, N. (2008). Adiponectin prevents cerebral ischemic injury through endothelial nitric oxide synthase dependent mechanisms. Circulation 117, 216-223.
78. Norata, G. D., Raselli, S., Grigore, L., Garlaschelli, K., Dozio, E., Magni, P., Catapano, A. L. (2007). Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke 38, 2844-2846.
79. Ogawa, Y., Masuzaki, H., Isse, N., Okazaki, T., Mori, K., Shigemoto, M., Satoh, N., Tamura, N., Hosoda, K., Yoshimasa, Y. (1995). Molecular cloning of rat obese cDNA, augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J. Clin. Invest. 96, 1647-1652.
80. Ohashi, K., Ouchi, N., Matsuzawa, Y. (2012). Anti-inflammatory, anti-atherogenic properties of adiponectin. Biochimie 94, 2137-2142.
81. Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013). A small-molecule AdipoR agonist for type 2 diabetes, short life in obesity. Nature 503, 493-499.
82. Ouchi, N., Walsh, K. (2007). Adiponectin as an anti-inflammatory factor. Clin. Chim. Acta 380, 24-30.
83. Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999). Novel modulator for endothelial adhesion molecules: Adipocyte-derived plasma protein adiponectin. Circulation 100, 2473-2476.
84. Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001). Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation, class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103, 1057-1063.
85. Ouchi, N., Kihara, S., Funahashi, T., Nakamura, T., Nishida, M., Kumada, M., Okamoto, Y., Ohashi, K., Nagaretani, H., Kishida, K., et al. (2003). Reciprocal association of C-reactive protein with adiponectin in blood stream, adipose tissue. Circulation 107, 671-674.
86. Ouedraogo, R., Wu, X., Xu, S. Q., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R., Goldstein, B. J. (2006). Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: Evidence for involvement of a cAMP signaling pathway. Diabetes 55, 1840-1846.
87. Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., Scherer, P. E. (2003). Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation, bioactivity. J. Biol. Chem. 278, 9073-9085.
88. Procaccini, C., Jirillo, E., Matarese, G. (2012). Leptin as an immunomodulator. Mol. Aspects Med. 33, 35-45.
89. Prugger, C., Luc, G., Haas, B., Arveiler, D., Machez, E., Ferrieres, J., Ruidavets, J. B., Bingham, A., Montaye, M., Amouyel, P., et al. (2012). Adipocytokines, the risk of ischemic stroke: The PRIME Study. Ann. Neurol. 71, 478-486.
90. Rajpathak, S. N., Kaplan, R. C., Wassertheil-Smoller, S., Cushman, M., Rohan, T. E., McGinn, A. P., Wang, T., Strickler, H. D., Scherer, P. E., Mackey, R., et al. (2011). Resistin, but not adiponectin, leptin, is associated with the risk of ischemic stroke among postmenopausal women: Results from the Women's Health Initiative. Stroke 42, 1813-1820.
91. Romero, JR., Morris, J., Pikula, A. (2008). Stroke prevention: Modifying risk factors. Ther. Adv. Cardiovasc. Dis. 2, 287-303.
92. Romero-Corral, A., Sierra-Johnson, J., Lopez-Jimenez, F., Thomas, R. J., Singh, P., Hoffmann, M., Okcay, A., Korinek, J., Wolk, R., Somers, V. K. (2008). Relationships between leptin, C-reactive protein with cardiovascular disease in the adult general population. Nat. Clin. Pract. Cardiovasc. Med. 5, 418-425.
93. Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N., Hailpern, S. M., Ho, M., Howard, V., Kissela, B., et al., American Heart Association Statistics, S. Stroke Statistics. (2008). Heart disease, stroke statistics-2008 update: A report from the American Heart Association Statistics Committee, Stroke Statistics Subcommittee. Circulation 117, e25-e146.
94. Saito, K., Tobe, T., Minoshima, S., Asakawa, S., Sumiya, J., Yoda, M., Nakano, Y., Shimizu, N., Tomita, M. (1999). Organization of the gene for gelatin-binding protein (GBP28). Gene 229, 67-73.
95. Sanchez-Margalet, V., Martin-Romero, C., Santos-Alvarez, J., Goberna, R., Najib, S., Gonzalez-Yanes, C. (2003). Role of leptin as an immunomodulator of blood mononuclear cells: Mechanisms of action. Clin. Exp. Immunol. 133, 11-19.
96. Saxena, N. K., Sharma, D., Ding, X., Lin, S., Marra, F., Merlin, D., Anania, F. A. (2007). Concomitant activation of the JAK/STAT, PI3K/AKT, ERK signaling is involved in leptin-mediated promotion of invasion, migration of hepatocellular carcinoma cells. Cancer Res. 67, 2497-2507.
97. Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., Lodish, H. F. (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270, 26746-26749.
98. Schneiderman, J., Schaefer, K., Kolodgie, F. D., Savion, N., Kotev-Emeth, S., Dardik, R., Simon, A. J., Halak, M., Pariente, C., Engelberg, I., et al. (2012). Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability, cerebral emboli. J. Am. Heart. Assoc. 1, e001727.
99. Shamsuzzaman, A. S., Winnicki, M., Wolk, R., Svatikova, A., Phillips, B. G., Davison, D. E., Berger, P. B., Somers, V. K. (2004). Independent association between plasma leptin, C-reactive protein in healthy humans. Circulation 109, 2181-2185.
100. Shapiro, L., Scherer, P. E. (1998). The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr. Biol. 8, 335-338.
101. Shibata, R., Murohara, T., Ouchi, N. (2012). Protective role of adiponectin in cardiovascular disease. Curr. Med. Chem. 19, 5459-5466.
102. Shimada, K., Miyazaki, T., Daida, H. (2004). Adiponectin, atherosclerotic disease. Clin. Chim. Acta 344, 1-12.
103. Siitonen, N., Pulkkinen, L., Lindstrom, J., Kolehmainen, M., Eriksson, J. G., Venojarvi, M., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Tuomilehto, J., Uusitupa, M. (2011). Association of ADIPOQ gene variants with body weight, type 2 diabetes, serum adiponectin concentrations: The Finnish Diabetes Prevention Study. BMC Med. Genet. 12, 5.
104. Singh, P., Hoffmann, M., Wolk, R., Shamsuzzaman, A. S., Somers, V. K. (2007). Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 27, e302-e307.
105. Soderberg, S., Ahren, B., Stegmayr, B., Johnson, O., Wiklund, P. G., Weinehall, L., Hallmans, G., Olsson, T. (1999). Leptin is a risk marker for first-ever hemorrhagic stroke in a populationbased cohort. Stroke 30, 328-337.
106. Soderberg, S., Stegmayr, B., Ahlbeck-Glader, C., Slunga-Birgander, L., Ahren, B., Olsson, T. (2003). High leptin levels are associated with stroke. Cerebrovasc. Dis. 15, 63-69.
107. Soderberg, S., Stegmayr, B., Stenlund, H., Sjostrom, L. G., Agren, A., Johansson, L., Weinehall, L., Olsson, T. (2004). Leptin, but not adiponectin, predicts stroke in males. J. Intern. Med. 256, 128-136.
108. Stott, D. J., Welsh, P., Rumley, A., Robertson, M., Ford, I., Sattar, N., Westendorp, R. G., Jukema, J. W., Cobbe, S. M., Lowe, G. D. (2009). Adipocytokines, risk of stroke in older people: A nested case-control study. Int. J. Epidemiol. 38, 253-261.
109. Stumvoll, M., Tschritter, O., Fritsche, A., Staiger, H., Renn, W., Weisser, M., Machicao, F., Haring, H. (2002). Association of the T-G polymorphism in adiponectin (exon 2) with obesity, insulin sensitivity: Interaction with family history of type 2 diabetes. Diabetes 51, 37-41.
110. Suk, S. H., Sacco, R. L., Boden-Albala, B., Cheun, J. F., Pittman, J. G., Elkind, M. S., Paik, M. C., S. Northern Manhattan Stroke. (2003). Abdominal obesity, risk of ischemic stroke: The Northern Manhattan Stroke Study. Stroke 34, 1586-1592.
111. Sweeney, G. (2010). Cardiovascular effects of leptin. Nat. Rev. Cardiol. 7, 22-29.
112. Takahashi, M., Arita, Y., Yamagata, K., Matsukawa, Y., Okutomi, K., Horie, M., Shimomura, I., Hotta, K., Kuriyama, H., Kihara, S., et al. (2000). Genomic structure, mutations in adiposespecific gene, adiponectin. Int. J. Obes. Relat. Metab. Disord. 24, 861-868.
113. Tartaglia, L. A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., Richards, G. J., Campfield, L. A., Clark, F. T., Deeds, J., et al. (1995). Identification, expression cloning of a leptin receptor, OB-R. Cell 83, 1263-1271.
114. Tian, L., Luo, N., Klein, R. L., Chung, B. H., Garvey, W. T., Fu, Y. (2009). Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis 202, 152-161.
115. Vaisse, C., Halaas, J. L., Horvath, C. M., Darnell, J. E., Jr., Stoffel, M., Friedman, J. M. (1996). Leptin activation of Stat3 in the hypothalamus of wild-type, ob/ob mice but not db/db mice. Nat. Genet. 14, 95-97.
116. Van Gaal, L. F., Mertens, I. L., De Block, C. E. (2006). Mechanisms linking obesity with cardiovascular disease. Nature 444, 875-880.
117. Wannamethee, S. G., Shaper, A. G., Whincup, P. H., Lennon, L., Sattar, N. (2013). Adiposity, adipokines, risk of incident stroke in older men. Stroke 44, 3-8.
118. Wong, G. W., Wang, J., Hug, C., Tsao, T. S., Lodish, H. F. (2004). A family of Acrp30/adiponectin structural, functional paralogs. Proc. Natl. Acad. Sci. USA 101, 10302-10307.
119. Wozniak, S. E., Gee, L. L., Wachtel, M. S., Frezza, E. E. (2009). Adipose tissue: The new endocrine organ A review article. Digest. Dis. Sci. 54, 1847-1856.
120. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy, obesity. Nat. Med. 7, 941-946.
121. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002). Adiponectin stimulates glucose utilization, fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295.
122. Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003). Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423, 762-769.
123. Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J. M. (1994). Positional cloning of the mouse obese gene, its human homologue. Nature 372, 425-432.
124. Zhu, W., Cheng, K. K., Vanhoutte, P. M., Lam, K. S., Xu, A. (2008). Vascular effects of adiponectin: Molecular mechanisms, potential therapeutic intervention. Clin. Sci. (Lond). 114, 361-374.